Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

7.92p

Change Today:

0.17p
52 Week High: 8.20
52 Week Low: 2.25

Currency: UK Pounds
Shares Issued: 1,041.69m
Volume: 4,215,295

Market Cap: £82.50m

STX Overview

Shield is a de-risked commercial stage, pharmaceutical company focused on addressing iron deficiency in adults with or without anaemia. Our clear purpose is to develop products that help patients become people again, enabling them to enjoy the things that make a difference in their everyday lives.

1 Day Chart

6 Month Chart

More Shield Therapeutics charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	-71.1%	-19.7%
ROCE	n/a

	Latest	F'cast
P/E	n/a	n/a
PEG	n/a	n/a
Pr/Revenue	2.5	2.0
Pr/Book	n/a

	Latest	F'cast
Revenue	145.9%	26.0%
PBT	n/a	n/a
EPS	n/a	n/a
DPS	n/a	n/a

STX Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-20	10.39	(1.89)	(1.89)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-21	1.52	(19.91)	(10.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-22	5.50	(49.43)	(21.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	13.09	(32.38)	(5.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-24	32.18	(26.56)	(3.00)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

STX Forecasts

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-25	40.54	(8.00)	(1.38)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-26	60.65	0.67	(0.45)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-27	92.28	17.67	1.57p	4.9	n/a	n/a	n/a	0.0%

Shield Therapeutics forecasts

STX Company Announcements

ACCRUFeR® assigned Priority Review in US by...	04-Sep-2025	07:03	RNS
Interim results for the six months ended 30 Jun 25	03-Sep-2025	14:17	RNS
Data published -European Journal of Heart Failure	27-Aug-2025	07:13	RNS

More Shield Therapeutics stx company announcements

STX ShareCast News

Shield Therapeutics gets FDA priority review to ...	04-Sep-2025	ShareCast
Shield Therapeutics reports sharp rise in first-...	03-Sep-2025	ShareCast
Shield Therapeutics inks exclusive licence agree...	22-Apr-2025	ShareCast

More Shield Therapeutics ShareCast news

Latest STX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

STX Market Data

Currency	UK Pounds
Share Price	7.92p
Change Today	0.17p
% Change	2.19 %
52 Week High	8.20
52 Week Low	2.25
Volume	4,215,295
Shares Issued	1,041.69m
Market Cap	£82.50m